| 溶解性 | DMSO |
| 存贮条件 | 储存温度-20°C |
| 生化机理 | Description:IC50 Value: N/ACebranopadol and GRT 6006 are novel first-in-class compounds with unique pharmacological and pharmacokinetic profiles that may enhance their effect in certain pain conditions. The unique mode of action of these compounds builds on the ORL-1 receptor and, supported by the established mu opioid receptor, is particularly suitable for the treatment of moderate to severe chronic pain [1].in vitro: N/Ain vivo: N/AClinical trial: Cebranopadol has successfully completed initial proof-of-concept studies in nociceptive and neuropathic pain with further Phase II studies planned prior to initiation of Phase III studies. |
| 别名 | ; |
脑帕多
Cebranopadol （订货以英文为准）
编号：C126216
CAS号：863513-91-1
分子式：C24H27FN2O
分子量：378.48
| 产品名称 | Cebranopadol |
| 中文名称 | 脑帕多 |
| CAS号 | 863513-91-1 |
| 分子式（M.F.） | C24H27FN2O |
| 分子量（M.W.） | 378.48 |
| 储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 2606.00
356234-5mL
¥ 81.00
P0017C-500mL
¥ 120.00
P0017B-250mL
¥ 328.00
W4201820250-25mL
¥ 450.00
G769603-(11X10ml)/EA
¥ 450.00
O769595-(11X10ml)/EA
¥ 450.00
Y769597-(11X10ml)/EA
¥ 450.00
B769593-(11X10ml)/EA
¥ 450.00
O769594-(11X10ml)/EA
¥ 168.00
FCP965-8pcs-1盒
党沛 
